KEGG   PATHWAY: oga04650
Entry
oga04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Otolemur garnettii (small-eared galago)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
oga04650  Natural killer cell mediated cytotoxicity
oga04650

Other DBs
GO: 0042267
Organism
Otolemur garnettii (small-eared galago) [GN:oga]
Gene
100940498  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
100941062  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100943020  SOS2; son of sevenless homolog 2 [KO:K03099]
100943120  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
100943579  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100943842  [KO:K06741]
100944134  [KO:K07360] [EC:2.7.10.2]
100944658  ITGB2; LOW QUALITY PROTEIN: integrin beta-2 [KO:K06464]
100945002  PRF1; LOW QUALITY PROTEIN: perforin-1 [KO:K07818]
100945309  [KO:K05414]
100945538  SHC4; SHC-transforming protein 4 [KO:K17449]
100945607  IFNG; interferon gamma [KO:K04687]
100945846  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X2 [KO:K04348] [EC:3.1.3.16]
100945944  [KO:K05414]
100946255  [KO:K05414]
100946957  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
100947138  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
100947275  VAV1; proto-oncogene vav isoform X1 [KO:K05730]
100947929  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100948274  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
100948398  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2 [KO:K01116] [EC:3.1.4.11]
100948701  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
100948829  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
100948893  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
100949583  NRAS; GTPase NRas isoform X1 [KO:K07828]
100949738  SH2D1A; SH2 domain-containing protein 1A isoform X2 [KO:K07990]
100949858  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100949905  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
100950236  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
100950628  VAV2; guanine nucleotide exchange factor VAV2 isoform X1 [KO:K05730]
100950969  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
100951008  FASLG; tumor necrosis factor ligand superfamily member 6 isoform X1 [KO:K04389]
100951369  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100951533  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100951644  HRAS; GTPase HRas isoform X1 [KO:K02833]
100951863  [KO:K07985]
100952204  CD244; natural killer cell receptor 2B4 [KO:K06582]
100952279  [KO:K06516]
100952580  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
100952728  RAET1E; retinoic acid early transcript 1E [KO:K07987]
100952749  SHC3; SHC-transforming protein 3 isoform X1 [KO:K17448]
100952960  TYROBP; TYRO protein tyrosine kinase-binding protein [KO:K07992]
100953050  KRAS; GTPase KRas isoform X3 [KO:K07827]
100953167  CD48; CD48 antigen [KO:K06479]
100953225  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
100953367  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
100953989  NCR2; LOW QUALITY PROTEIN: natural cytotoxicity triggering receptor 2 [KO:K06742]
100954109  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100954541  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
100954597  [KO:K06541]
100954911  [KO:K06541]
100955048  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
100955220  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X2 [KO:K17332]
100955336  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
100955860  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X2 [KO:K07293] [EC:3.1.3.48]
100955951  [KO:K05414]
100956072  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X2 [KO:K04369] [EC:2.7.12.2]
100956838  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
100956877  PRKCG; protein kinase C gamma type isoform X2 [KO:K19663] [EC:2.7.11.13]
100956963  [KO:K05414]
100957036  LAT; linker for activation of T-cells family member 1 [KO:K07362]
100957079  [KO:K01353] [EC:3.4.21.79]
100957182  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100957343  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100957388  [KO:K01353] [EC:3.4.21.79]
100957574  [KO:K05414]
100957582  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
100957623  SHC2; SHC-transforming protein 2 [KO:K17447]
100957699  [KO:K01353] [EC:3.4.21.79]
100957974  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
100958244  SH2D1B; SH2 domain-containing protein 1B isoform X1 [KO:K07989]
100958428  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
100958440  [KO:K05414]
100958512  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
100958517  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
100958617  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
100958763  [KO:K05414]
100959074  [KO:K05414]
100959107  [KO:K01353] [EC:3.4.21.79]
100959197  [KO:K06463]
100959248  IFNAR2; interferon alpha/beta receptor 2 isoform X1 [KO:K05131]
100959385  IFNB1; interferon beta [KO:K05415]
100959766  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
100959926  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100960147  [KO:K06541]
100960302  BID; BH3-interacting domain death agonist [KO:K04726]
100960488  [KO:K04722]
100960904  IFNGR1; interferon gamma receptor 1 isoform X1 [KO:K05132]
100961025  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform [KO:K04348] [EC:3.1.3.16]
100961309  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
100961435  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
100961499  [KO:K01353] [EC:3.4.21.79]
100961610  [KO:K06541]
100961754  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
100962147  [KO:K24233]
100962353  [KO:K05414]
100962661  [KO:K06541]
100963176  [KO:K06541]
100963265  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
100963323  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
100963497  [KO:K24233]
100963613  TNF; tumor necrosis factor [KO:K03156]
100963813  [KO:K24233]
100964084  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
100964535  [KO:K06728]
100964543  [KO:K24233]
100964949  LCK; tyrosine-protein kinase Lck [KO:K05856] [EC:2.7.10.2]
100964977  [KO:K06541]
100965262  SH3BP2; SH3 domain-binding protein 2 isoform X1 [KO:K07984]
100965377  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100965414  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
100965478  [KO:K06516]
100965487  [KO:K06541]
100965552  [KO:K06464]
100965794  [KO:K06516]
100966694  SHC1; SHC-transforming protein 1 isoform X2 [KO:K06279]
105886540  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
105887331  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
105888418  [KO:K06541]
111722921  [KO:K07987]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
oga04010  MAPK signaling pathway
oga04020  Calcium signaling pathway
oga04060  Cytokine-cytokine receptor interaction
oga04210  Apoptosis
oga04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system